The independent laboratory, based in the Nice Côte d’Azur Metropolis, Horus Pharma, is continuing its European expansion by opening a subsidiary in the Nordic countries.
Based in Stockholm, Horus Pharma Nordic will cover Sweden, Norway, Finland, and Denmark.
Horus Pharma specializes in ophthalmology and develops, patents, and markets preservative-free products and solutions for the care of the eyes and eyelids.
The full range of Horus Pharma products, including medical devices for the treatment of glaucoma, allergies, inflammation, dry eye, surgical and peri-surgical solutions, as well as cosmetic products for eyelid hygiene, will gradually become available in the Nordic market over the next year.
The French laboratory is already present in Spain, Benelux, and Switzerland.
Horus Pharma is also committed to protecting the environment through its Eco’Ophtalmo program, which aims to reduce its ecological footprint and raise awareness among ophthalmologists about the environmental impact of medical practices.
The group strives to develop environmentally responsible initiatives, such as the environmental and social commitment to achieving plastic neutrality and the development of FSC certified recyclable packaging.
Claude Claret is the CEO and co-founder of Horus Pharmahas stated, “I am proud of our growth and expansion in Europe, which now includes the Nordic countries. Our ambition is to play a key role in the Nordic countries by bringing advanced solutions to ophthalmologists and their patients.”
Johan Marlowe, General Manager of Horus Pharma Nordic, stated that he is “honored to embark on this mission with Horus Pharma” and is committed to meeting the expectations of the Nordic market by offering innovative solutions to optimize patient care.
Source: Horus Pharma press release
Healthtech News – Nice Côte d’Azur
- Circum Medtech Pharma expands its industrial development in Tunisia from Nice
- Japan Entry Acceleration Program: a launchpad towards the Japanese market for innovative health startups
- TIGER e-health: the Côte d’Azur integrates into alpine innovation
- The Nice-based biotech Roca Therapeutics reaches a new milestone in its development
- Team Nice Côte d’Azur on a mission at the International Congress of Nutrition 2025
- Horus Pharma accelerates its international expansion across 8 new countries
- Health Afterwork in Nice: connecting innovators in the HealthTech sector
- Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation
- Klava Innovation and Isis Medical: a partnership serving respiratory health
- Nice awarded the “Ma Ville se Ligue” label for its health prevention policy
